Gate Bioscience
Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease. The company combines ...
Valuation
$161M
Market implied
Share Price
N/A
Total Raised
$134.5M
Last Round
N/A